American Cryostem Corp (CRYO) financial statements (2021 and earlier)

Company profile

Business Address 1 MERIDIAN ROAD
EATONTOWN, NJ 07724
State of Incorp. NV
Fiscal Year End September 30
SIC 809 - Miscellaneous Health And Allied Services, Not (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
3/31/2020
Q2
12/31/2019
Q1
9/30/2019
Q4
6/30/2019
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments31422911822454
Cash and cash equivalents31422911822454
Receivables627500376253450330201
Inventory, net of allowances, customer advances and progress billings22204037262627
Inventory22204037262627
Prepaid expense135     
Total current assets:692567444302558380282
Noncurrent Assets
Finance lease, right-of-use asset8186909598  
Operating lease, right-of-use asset1018263340  
Property, plant and equipment123127128132132238250
Long-term investments and receivables     300 
Long-term investments     300 
Intangible assets, net (including goodwill)373366364365363362354
Intangible assets, net (excluding goodwill)373366364365363362354
Other undisclosed noncurrent assets31431431431431414315
Total noncurrent assets:901910921938947914919
TOTAL ASSETS:1,5941,4771,3651,2401,5051,2941,201
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:191182198274230322277
Accounts payable     189 
Other undisclosed accounts payable and accrued liabilities191182198274230133277
Debt598600597664520399386
Derivative instruments and hedges, liabilities   127259  
Estimated litigation liability202411812410197101
Due to related parties  3334184 168
Other liabilities227227227227227227227
Other undisclosed current liabilities101826371724834
Total current liabilities:1,0451,0501,1981,4881,5371,2921,193
Noncurrent Liabilities
Long-term debt and lease obligation9  1013810294
Long-term debt, excluding current maturities9   11010294
Finance lease, liability   717  
Operating lease, liability   310  
Liabilities, other than long-term debt9999204204204211204
Due to related parties9999204204204211204
Other undisclosed noncurrent liabilities8007491,0931,020960927876
Total noncurrent liabilities:9088481,2971,2341,3021,2401,175
Total liabilities:1,9531,8982,4952,7222,8402,5322,367
Stockholders' equity
Stockholders' equity attributable to parent(360)(421)(1,129)(1,482)(1,335)(1,238)(1,167)
Common stock60605450504949
Additional paid in capital16,02415,91714,68514,10614,10613,93213,912
Accumulated deficit(16,444)(16,398)(15,868)(15,638)(15,491)(15,219)(15,128)
Total stockholders' equity:(360)(421)(1,129)(1,482)(1,335)(1,238)(1,167)
TOTAL LIABILITIES AND EQUITY:1,5941,4771,3651,2401,5051,2941,201

Income statement (P&L) ($ in thousands)

12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
3/31/2020
Q2
12/31/2019
Q1
9/30/2019
Q4
6/30/2019
Q3
Revenues12712513816113314913
Cost of revenue(3)(23)(5)(12)(5)(4)(2)
Provision for loan, lease, and other losses    (93)  
Gross profit:12310213415012814510
Operating expenses(172)(561)(134)(502)(218)(203)(319)
Operating income (loss):(49)(459)0(352)(90)(57)(309)
Nonoperating income (expense) 00  (3) 
Foreign currency transaction gain, before tax 00    
Interest and debt expense(16)(14)(19)(24)(22)(17)(17)
Loss from continuing operations before equity method investments, income taxes:(65)(473)(18)(376)(112)(78)(326)
Other undisclosed income (loss) from continuing operations before income taxes (57)(212)229(160)(14)(18)
Loss before gain (loss) on sale of properties:(65)(530)(230)(147)(272)(91)(344)
Other undisclosed net income19      
Net loss available to common stockholders, diluted:(46)(530)(230)(147)(272)(91)(344)

Comprehensive Income ($ in thousands)

12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
3/31/2020
Q2
12/31/2019
Q1
9/30/2019
Q4
6/30/2019
Q3
Net loss:(46)(530)(230)(147)(272)(91)(344)
Comprehensive loss, net of tax, attributable to parent:(46)(530)(230)(147)(272)(91)(344)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: